Randy L. Anderson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Randy L. Anderson has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
David L. Bowton
Departments of Anesthesia (Section on Critical Care Medicine), Medicine (Section on Pulmonary and Critical Care Medicine), and Public Health Sciences, the Bowman Cray School of Medicine of Wake Forest University, Winston-Salem, North Carolina
3 shared publicationsPhillip E. Scuderi
Department of Anesthesia, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC 27157
3 shared publicationsAmi Laws
Department of Medicine, Stanford Medical School Palo Alto, CA
2 shared publicationsLynne C. Harris
Departments of Anesthesia (Section on Critical Care Medicine), Medicine (Section on Pulmonary and Critical Care Medicine), and Public Health Sciences, the Bowman Cray School of Medicine of Wake Forest University, Winston-Salem, North Carolina
2 shared publicationsAudrey B. Tuttle
1 shared publicationAudrey Bell-Farrow
1 shared publication
Latest Publications
- 1 October 1995
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 142 (7) , 724-732
A BREIF ORIGINAL CONTRIBUTION
Both abnormal insulin levels and low insulin sensitivity have been implicated as risk factors for Type II diabetes mellitus and cardiovascular disease. While insulin level is relatively simple to assess, direct measurement of insulin sensitivity is much more invasive, costly, and time-consuming. The authors considered eight previously described measures or indices of insulin sensitivity derived from the frequently sampled intravenous glucose tolerance test (FSIGT). Each one was evaluated by strength and consistency of association with insulin sensitivity computed from glucose clamp (S1(clamp)), across three glucose tolerance groups, including participants with normal glucose tolerance (n = 11), impaired glucose tolerance (n = 20), and non-insulin-dependent diabetes mellitus (n = 24). Minimal model analysis (MINMOD S1(22)), based on the 22-sample FSIGT, performed best based on statistical criteria of strong and consistent association with S1(clamp). An insulin sensitivity measure similar to that of Galvin et al. (Diabetic Medicine 1990;9:921–8), defined as glucose disappearance (10–50 minutes) divided by insulin area under the curve above baseline from 0–50 minutes, performed best based on statistical criteria and time-savings. Galvin insulin sensitivity is simple to calculate, requires only a 50–minute FSIGT, and is significantly (p ≤ 0.001) and not inconsistently (p = 0.12 for inconsistent association) associated with S1(clamp) over a wide range of glucose tolerance. Am J Epidemiol 1995;142:724–32.
- 1 October 1995
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 142 (7) , 724-732
A BREIF ORIGINAL CONTRIBUTION
Both abnormal insulin levels and low insulin sensitivity have been implicated as risk factors for Type II diabetes mellitus and cardiovascular disease. While insulin level is relatively simple to assess, direct measurement of insulin sensitivity is much more invasive, costly, and time-consuming. The authors considered eight previously described measures or indices of insulin sensitivity derived from the frequently sampled intravenous glucose tolerance test (FSIGT). Each one was evaluated by strength and consistency of association with insulin sensitivity computed from glucose clamp (S1(clamp)), across three glucose tolerance groups, including participants with normal glucose tolerance (n = 11), impaired glucose tolerance (n = 20), and non-insulin-dependent diabetes mellitus (n = 24). Minimal model analysis (MINMOD S1(22)), based on the 22-sample FSIGT, performed best based on statistical criteria of strong and consistent association with S1(clamp). An insulin sensitivity measure similar to that of Galvin et al. (Diabetic Medicine 1990;9:921–8), defined as glucose disappearance (10–50 minutes) divided by insulin area under the curve above baseline from 0–50 minutes, performed best based on statistical criteria and time-savings. Galvin insulin sensitivity is simple to calculate, requires only a 50–minute FSIGT, and is significantly (p ≤ 0.001) and not inconsistently (p = 0.12 for inconsistent association) associated with S1(clamp) over a wide range of glucose tolerance. Am J Epidemiol 1995;142:724–32.
- 1 July 1995
- Published by Elsevier in Metabolism
- Vol. 44 (7) , 954-959
Contribution of visceral fat mass to the insulin resistance of aging
- 1 July 1995
- Published by Elsevier in Metabolism
- Vol. 44 (7) , 954-959
Contribution of visceral fat mass to the insulin resistance of aging
- 1 February 1995
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 194 (2) , 469-476
Periventricular venous collagenosis: association with leukoaraiosis.
To investigate the association between an age-related degenerative disease of subependymal veins and leukoaraiosis. Brains obtained at autopsy from 22 patients (average age, 73.2 years; range, 25-95 years) were examined with magnetic resonance (MR) imaging and neuropathologic methods with alkaline phosphatase microvascular staining. The degrees of leukoaraiosis shown on MR images and of deep venous occlusion were scored independently and results compared with logistic regression analysis. Noninflammatory collagenous thickening of venous walls resulting in severe periventricular venous stenosis was found in 13 (65%) of 20 patients over 60 years old. Advanced leukoaraiosis was found in 10 (77%) of these 13 patients. Greater venous disease was associated with more severe leukoaraiosis. Periventricular venous collagenosis, a commonly observed and previously ignored degenerative disease of elderly humans, is strongly associated with leukoaraiosis. Stenosis or occlusion of deep cerebral veins may promote development of leukoaraiosis.
- 1 February 1995
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 194 (2) , 469-476
Periventricular venous collagenosis: association with leukoaraiosis.
To investigate the association between an age-related degenerative disease of subependymal veins and leukoaraiosis. Brains obtained at autopsy from 22 patients (average age, 73.2 years; range, 25-95 years) were examined with magnetic resonance (MR) imaging and neuropathologic methods with alkaline phosphatase microvascular staining. The degrees of leukoaraiosis shown on MR images and of deep venous occlusion were scored independently and results compared with logistic regression analysis. Noninflammatory collagenous thickening of venous walls resulting in severe periventricular venous stenosis was found in 13 (65%) of 20 patients over 60 years old. Advanced leukoaraiosis was found in 10 (77%) of these 13 patients. Greater venous disease was associated with more severe leukoaraiosis. Periventricular venous collagenosis, a commonly observed and previously ignored degenerative disease of elderly humans, is strongly associated with leukoaraiosis. Stenosis or occlusion of deep cerebral veins may promote development of leukoaraiosis.
- 1 October 1994
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 150 (4) , 1002-1005
Effect of Chronic Theophylline Therapy on Brain Blood Flow and Function in Adult Asthmatics
The impact of theophylline therapy on neuropsychological (NP) function in adult asthmatics is unclear. Additionally, whether the previously demonstrated acute reduction in cerebral blood flow (CBF) persists with continued administration of theophylline, or whether accommodation develops, has not been previously reported. We examined the effects of chronic theophylline administration on CBF and NP function in adults with mild to moderate asthma. Sixty adult patients with mild to moderate asthma were entered into this double-blind, placebo-controlled, crossover, random sequence study. Subjects received theophylline or placebo for 6 wk interposed with a 2-wk washout period. At the conclusion of Week 1 and Week 6 of each drug phase, patients received NP testing, and CBF was determined using the 133Xenon washout method. Forty-three patients completed the study. Theophylline administration was associated with small (6%), but statistically significant, reductions in CBF after both 1 and 6 wk of treatment. No differences consequent to theophylline administration were observed in any of the tests of NP function after 1 or 6 wk of therapy. While CBF was decreased after theophylline, the changes were small compared with previously reported decrements in CBF immediately after theophylline administration.
- 1 October 1994
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 150 (4) , 1002-1005
Effect of Chronic Theophylline Therapy on Brain Blood Flow and Function in Adult Asthmatics
The impact of theophylline therapy on neuropsychological (NP) function in adult asthmatics is unclear. Additionally, whether the previously demonstrated acute reduction in cerebral blood flow (CBF) persists with continued administration of theophylline, or whether accommodation develops, has not been previously reported. We examined the effects of chronic theophylline administration on CBF and NP function in adults with mild to moderate asthma. Sixty adult patients with mild to moderate asthma were entered into this double-blind, placebo-controlled, crossover, random sequence study. Subjects received theophylline or placebo for 6 wk interposed with a 2-wk washout period. At the conclusion of Week 1 and Week 6 of each drug phase, patients received NP testing, and CBF was determined using the 133Xenon washout method. Forty-three patients completed the study. Theophylline administration was associated with small (6%), but statistically significant, reductions in CBF after both 1 and 6 wk of treatment. No differences consequent to theophylline administration were observed in any of the tests of NP function after 1 or 6 wk of therapy. While CBF was decreased after theophylline, the changes were small compared with previously reported decrements in CBF immediately after theophylline administration.
- 1 September 1994
- Published by American Diabetes Association in Diabetes
- Vol. 43 (9) , 1114-1121
A Comparison Between the Minimal Model and the Glucose Clamp in the Assessment of Insulin Sensitivity Across the Spectrum of Glucose Tolerance
An insulin-modified frequently sampled intravenous glucose tolerance test (FSIGTT) with minimal model analysis was compared with the glucose clamp in 11 subjects with normal glucose tolerance (NGT), 20 with impaired glucose tolerance (IGT), and 24 with non-insulin-dependent diabetes mellitus (NIDDM). The insulin sensitivity index (SI) was calculated from FSIGTT using 22- and 12-sample protocols (SI(22) and SI(12), respectively). Insulin sensitivity from the clamp was expressed as SI(clamp) and SIP(clamp). Minimal model parameters were similar when calculated with SI(22) and SI(12). SI could not be distinguished from 0 in ∼ 50% of diabetic patients with either protocol. SI(22) correlated significantly with SI(clamp) in the whole group (r = 0.62), and in the NGT (r = 0.53), IGT (r = 0.48), and NIDDM (r = 0.41) groups (P < 0.05 for each). SI(12) correlated significantly with SI(clamp) in the whole group (r = 0.55, P < 0.001) and in the NGT (r = 0.53, P = 0.046) and IGT (r = 0.58, P = 0.008) but not NIDDM (r = 0.30, P = 0.085) groups. When SI(22), SI(clamp), and SIP(clamp) were expressed in the same units, SI(22) was 66 ± 5% (mean ± SE) and 50 ± 8% lower than SI(clamp) and SIP(clamp), respectively. Thus, minimal model analysis of the insulin-modified FSIGTT provides estimates of insulin sensitivity that correlate significantly with those from the glucose clamp. The correlation was weaker, however, in NIDDM. The insulin-modified FSIGTT can be used as a simple test for assessment of insulin sensitivity in population studies involving nondiabetic subjects. Additional studies are needed before using this test routinely in patients with NIDDM.
- 1 September 1994
- Published by American Diabetes Association in Diabetes
- Vol. 43 (9) , 1114-1121
A Comparison Between the Minimal Model and the Glucose Clamp in the Assessment of Insulin Sensitivity Across the Spectrum of Glucose Tolerance
An insulin-modified frequently sampled intravenous glucose tolerance test (FSIGTT) with minimal model analysis was compared with the glucose clamp in 11 subjects with normal glucose tolerance (NGT), 20 with impaired glucose tolerance (IGT), and 24 with non-insulin-dependent diabetes mellitus (NIDDM). The insulin sensitivity index (SI) was calculated from FSIGTT using 22- and 12-sample protocols (SI(22) and SI(12), respectively). Insulin sensitivity from the clamp was expressed as SI(clamp) and SIP(clamp). Minimal model parameters were similar when calculated with SI(22) and SI(12). SI could not be distinguished from 0 in ∼ 50% of diabetic patients with either protocol. SI(22) correlated significantly with SI(clamp) in the whole group (r = 0.62), and in the NGT (r = 0.53), IGT (r = 0.48), and NIDDM (r = 0.41) groups (P < 0.05 for each). SI(12) correlated significantly with SI(clamp) in the whole group (r = 0.55, P < 0.001) and in the NGT (r = 0.53, P = 0.046) and IGT (r = 0.58, P = 0.008) but not NIDDM (r = 0.30, P = 0.085) groups. When SI(22), SI(clamp), and SIP(clamp) were expressed in the same units, SI(22) was 66 ± 5% (mean ± SE) and 50 ± 8% lower than SI(clamp) and SIP(clamp), respectively. Thus, minimal model analysis of the insulin-modified FSIGTT provides estimates of insulin sensitivity that correlate significantly with those from the glucose clamp. The correlation was weaker, however, in NIDDM. The insulin-modified FSIGTT can be used as a simple test for assessment of insulin sensitivity in population studies involving nondiabetic subjects. Additional studies are needed before using this test routinely in patients with NIDDM.
- 1 August 1994
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 171 (2) , 350-358
Expectant management of preterm premature rupture of the membranes
- 1 August 1994
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 171 (2) , 350-358
Expectant management of preterm premature rupture of the membranes
- 1 June 1993
- Published by Oxford University Press (OUP) in American Review of Respiratory Disease
- Vol. 147 (6_Part_1) , 1354-1359
Performance Characteristics and Interanalyzer Variability of PO2 Measurements Using Tonometered Human Blood
We performed a side-by-side comparison of the ability of four blood gas analyzers (IL-1312, Corning-178, AVL-995, and ABL-330) to measure PO2 across a wide range under controlled laboratory conditions. Samples of fresh whole human blood, tonometered with analytic quality gas, were prepared with partial pressures of oxygen from 0 to 283 mm Hg. Fifteen determinations were made at 16 levels of tonometric PO2 (tPO2) on each of the four blood gas analyzers. The bias, precision, and root mean squared error (RMSE) of the PO2 measurement relative to tPO2 were determined for each analyzer at each tPO2 level. Mean bias and precision across the range tested were 2.78 ± 1.29 mm Hg (IL), −0.35 ± 1.91 (Corning), 2.14 ± 1.43 (AVL), and 3.00 ± 1.47 (ABL). RMSE was 3.28, 2.61, 3.57, and 2.41 for IL, AVL, ABL, and Corning, respectively. Percent RMSE (RMSE/ tPO2 × 100%), ranged from 0.9% (AVL at 75 mm Hg PO2 and IL at 283 mm Hg tPO2) to 9.1% (IL at 29 mm Hg tPO2). Three analyzers (AVL, ABL, and Corning) showed a statistically significant (p < 0.0001) correlation between RMSE and tPO2, and no correlation between percent RMSE and tPO2. This demonstrates that, for these instruments, accuracy is a function of the magnitude of the tPO2 value. IL did not show a significant correlation between RMSE and tPO2 but did demonstrate a significant negative correlation (r = −0.78, p > 0.001) between percent RMSE and tPO2, indicating that, for this analyzer, accuracy is not a function of tPO2. The differences in PO2 measurements between pairs of analyzers were also examined. The mean ± 95% confidence limits for the overall differences ranged from a low of −0.87 ± 3.90 (AVL - ABL pair) to a high of 3.30 ± 7.49 (ABL - Corning pair), owing to the analyzer-specific differences in systematic tendency to over- or underestimate the target PO2 (ie, positive or negative bias). There are statistically significant differences in both means and variances between pairs of blood gas analyzers across most of the ranges of tPO2 tested. Under controlled laboratory conditions, the bias ranges from −3.06% to 8.62% and precision from 0.82% to 3.76% of the tPO2 on any one analyzer; however, interanalyzer differences in reported PO2 of 10% or more (95% confidence limit) could occur if the same sample were run concurrently on two different brands of blood gas analyzers.
- 1 June 1993
- Published by Oxford University Press (OUP) in American Review of Respiratory Disease
- Vol. 147 (6_Part_1) , 1354-1359
Performance Characteristics and Interanalyzer Variability of PO2 Measurements Using Tonometered Human Blood
We performed a side-by-side comparison of the ability of four blood gas analyzers (IL-1312, Corning-178, AVL-995, and ABL-330) to measure PO2 across a wide range under controlled laboratory conditions. Samples of fresh whole human blood, tonometered with analytic quality gas, were prepared with partial pressures of oxygen from 0 to 283 mm Hg. Fifteen determinations were made at 16 levels of tonometric PO2 (tPO2) on each of the four blood gas analyzers. The bias, precision, and root mean squared error (RMSE) of the PO2 measurement relative to tPO2 were determined for each analyzer at each tPO2 level. Mean bias and precision across the range tested were 2.78 ± 1.29 mm Hg (IL), −0.35 ± 1.91 (Corning), 2.14 ± 1.43 (AVL), and 3.00 ± 1.47 (ABL). RMSE was 3.28, 2.61, 3.57, and 2.41 for IL, AVL, ABL, and Corning, respectively. Percent RMSE (RMSE/ tPO2 × 100%), ranged from 0.9% (AVL at 75 mm Hg PO2 and IL at 283 mm Hg tPO2) to 9.1% (IL at 29 mm Hg tPO2). Three analyzers (AVL, ABL, and Corning) showed a statistically significant (p < 0.0001) correlation between RMSE and tPO2, and no correlation between percent RMSE and tPO2. This demonstrates that, for these instruments, accuracy is a function of the magnitude of the tPO2 value. IL did not show a significant correlation between RMSE and tPO2 but did demonstrate a significant negative correlation (r = −0.78, p > 0.001) between percent RMSE and tPO2, indicating that, for this analyzer, accuracy is not a function of tPO2. The differences in PO2 measurements between pairs of analyzers were also examined. The mean ± 95% confidence limits for the overall differences ranged from a low of −0.87 ± 3.90 (AVL - ABL pair) to a high of 3.30 ± 7.49 (ABL - Corning pair), owing to the analyzer-specific differences in systematic tendency to over- or underestimate the target PO2 (ie, positive or negative bias). There are statistically significant differences in both means and variances between pairs of blood gas analyzers across most of the ranges of tPO2 tested. Under controlled laboratory conditions, the bias ranges from −3.06% to 8.62% and precision from 0.82% to 3.76% of the tPO2 on any one analyzer; however, interanalyzer differences in reported PO2 of 10% or more (95% confidence limit) could occur if the same sample were run concurrently on two different brands of blood gas analyzers.
- 1 February 1992
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 74 (2) , 177-180
Pulse Oximetry
- 1 February 1992
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 74 (2) , 177-180
Pulse Oximetry
- 1 January 1992
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 19 (1) , 45-48
The Thomas Shunt Revisited
- 1 January 1992
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 19 (1) , 45-48
The Thomas Shunt Revisited